Loading...
Press Releases 2017-09-21T11:12:50+00:00

News & Press Releases

SHINE Teams with LifeSci

2017-LifeSci-Social-Mini-Graphic
December 11, 2017

December 11, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has joined forces with investor relations firm, LifeSci Advisors, LLC (“LifeSci”) to anchor its outreach to the broader investment community.  LifeSci is […]..Read More

SHINE Building One 90 Day Progress

SHINE-Building-One-90-Day-Progress-Title-Screen
October 18, 2017

Building One construction continues on schedule! Over 60 on-site work days with 0 accidents. Way to go JP Cullen! To view our other videos, visit our YouTube channel and hit subscribe to see the most recent and future updates...Read More

SHINE Expands Patent Portfolio

2017-SHINE-patent-social-mini
September 28, 2017

U.S. Patent No. 9,734,926 relates to producing medical isotopes and expires December 23, 2032. This achievement demonstrates SHINE’s ongoing commitment to innovation and leadership in the medical isotope industry. ..Read More

SHINE Selects Baker Concrete Construction

Baker - SHINE Production Facility Rendering
September 6, 2017

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has chosen Baker Concrete Construction, Inc. (Baker) to be the prime contractor for the construction of its medical isotope production facility in Janesville, Wisconsin.  In conjunction, Brad Wucherpfennig, President of Baker, has joined the SHINE board of directors...Read More

SHINE Presents at 2017 Mo-99 Topical Meeting

2017-Mo-99-Topical-Meeting-Graphic
September 1, 2017

September 1, 2017  – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2017 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security […]..Read More

Miltenberger Promoted to Chief of Staff

Steve-Miltenberger-PR-Photo
August 24, 2017

August 24, 2017  – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Steve Miltenberger has been promoted to Chief of Staff. The announcement comes as the company prepares to build its facility in Janesville, Wisconsin, […]..Read More

SHINE Breaks Ground on Building One

SHINE-B1-Groundbreaking-Leaders
August 4, 2017

August 4, 2017 Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a groundbreaking ceremony yesterday to celebrate the start of construction on Building One. The first building to be built for the SHINE campus, Building One will […]..Read More

Martyn Coombs to Advise SHINE

Martyn-Coombs_Headshot
March 27, 2017

March 27, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Martyn Coombs will become a Strategic Adviser to SHINE, on a part-time basis.  The announcement comes as the company prepares to build its […]..Read More

Gregory OD Smith Joins SHINE BOD

Gregory Smith
February 13, 2017

February 13th, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly‑99) and other medical isotopes...Read More

Grand Opening of new SHINE Global HQ

SHINE HQ Ribbon Cutting
January 16, 2017

January 16, 2017 - SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors...Read More

SHINE Awarded $20.9M DOE/NNSA Phase II

December 12, 2016

December 12, 2016 - SHINE Medical Technologies announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement. ..Read More

SHINE to Present at Piper Jaffray Healthcare Conference

Piper Jaffray Logo
November 17, 2016

November 17, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 28th Annual Piper Jaffray Healthcare Conference in New York...Read More

SHINE to Move HQ to Janesville, Wisconsin

City-Of-Janesville-Logo
September 21, 2016

September 23, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year...Read More

SHINE to Present at Mo-99 Topical Meeting

September 6, 2016

September 6, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA)...Read More

George Hansrote Joins SHINE

George-Hansrote-Post-Headshot
July 13, 2016

July 13, 2016 - SHINE Medical Technologies announced today that George Hansrote will join the company as Vice President of Project Delivery, to manage the construction of the SHINE radioisotope production facility...Read More

HTA and SHINE Sign Mo-99 Supply Agreement

HTA Supply Agreement
June 21, 2016

June 21, 2016 - HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99)...Read More

Phoenix and SHINE Complete Unprecedented Neutron Production Run

Phoenix Nuclear Labs
March 22, 2016

March 22, 2016 - Phoenix Nuclear Labs (PNL) and SHINE Medical Technologies (SHINE) announced today that they successfully operated their accelerator-based neutron generator for 132 consecutive hours with greater than 97% uptime. ..Read More

NRC Issues SHINE Construction Permit

NRC Construction Permit
February 25, 2016

February 25, 2016 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit. ..Read More

SHINE CEO Awarded Top Honors by UW

UW-Early-Career-Achievement-Award
January 11, 2016

January 11, 2016 - The University of Wisconsin-Madison College of Engineering has awarded Dr. Greg Piefer, founder and CEO of SHINE Medical Technologies, Inc. (SHINE) the Early-Career Achievement Award. ..Read More

SHINE Holds 2nd 2015 Community Meeting

December 7, 2015

December 7, 2015 - SHINE invites the Janesville community to an update on the development of its medical isotope production facility. Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility...Read More

It Takes Two: GE Healthcare and SHINE Team Up

GE Drytek Generators
November 9, 2015

November 9, 2015 - Today, SHINE and GE Healthcare announced they have successfully obtained pharmaceutical-grade Tc‑99m from GE Healthcare’s DRYTEC™ Tc-99m (Kit for the Preparation of Sodium Pertechnetate Technetium Tc99m Injection), using Mo-99 produced by SHINE’s innovative process...Read More

SHINE Achieves Major Milestone on Path to Construction Permit Approval

NRC Hearing
October 26, 2015

October 26, 2015 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the staff of its primary regulator, the Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility. ..Read More

Additional $2M DOE/NNSA Award Accelerates SHINE Project

October 25, 2015

October 25, 2015 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based medical isotope company, announced today that it has been awarded $1 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $2 million cooperative agreement. ..Read More

SHINE Signs License Agreement for SRNL Innovation

October 14, 2015

October 14, 2015 - Savannah River Nuclear Solutions, LLC (SRNS), the management and operating contractor for the U.S. Department of Energy’s Savannah River National Laboratory (SRNL), has granted SHINE Medical Technologies, Inc. (SHINE) an exclusive license on SRNL’s patented hydrogen isotope separation process for use in medical isotope production...Read More

Todd Asmuth Joins SHINE Team

October 1, 2015

October 1, 2015 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Todd Asmuth will join the company as President, reporting to the CEO and focusing on investor and customer relations. The appointment comes as the company prepares to bring its first product to market, molybdenum-99 (moly-99)...Read More

NSF Award Accelerates SHINE Efforts to Become a Major Iodine-131 Producer

June 30, 2015

June 30, 2015 - SHINE Medical Technologies, a Wisconsin-based medical isotope company, announced today that it has been awarded $150,000 from the National Science Foundation for Phase I of an SBIR (Small Business Innovation Research) Grant. This grant will fast-track SHINE’s ongoing development of iodine-131 extraction and purification processes, which SHINE may decide to pursue at its medical isotope production facility...Read More

Argonne Demo of SHINE Process Produces Commercial-Grade Medical Isotopes

ANL Hotcell
June 15, 2015

June 15, 2015 - Argonne National Laboratory (Argonne) and SHINE Medical Technologies, Inc. announced today that Argonne successfully demonstrated the production, separation and purification of molybdenum-99 (Mo-99) from SHINE’s innovative liquid target. The resulting Mo-99 product purity was equivalent to the Mo-99 used in the supply chain today. The demonstration—known as Mini-SHINE— uses the same process flows that will be used in the SHINE manufacturing facility and further validates SHINE’s technical approach...Read More

NRC Issues Draft EIS for SHINE Facility

May 21, 2015

May 21, 2015 - SHINE Medical Technologies, a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that the Company’s primary regulator, the Nuclear Regulatory Commission (NRC), has released for public review and comment the draft Environmental Impact Statement (EIS) for the SHINE medical isotope production facility in Janesville, WI. ..Read More

SHINE and Phoenix Sign Development and Supply Agreement

Phoenix Nuclear Labs
January 7, 2015

January 7, 2015 - SHINE Medical Technologies and Phoenix Nuclear Labs (PNL) announced today that they have entered into an exclusive, long-term development and supply agreement. This agreement builds on an existing partnership and lays the foundation for a commercial relationship going forward...Read More

Lantheus and SHINE Announce Mo-99 Supply Agreement

Lantheus Medical Imaging
November 5, 2014

November 5, 2014 - Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, and SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, today announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99)...Read More

SHINE Signs $125M Term Sheet

October 10, 2014

SHINE Medical Technologies, Inc. (SHINE) announced today that it executed a term sheet providing for up to $125 million of debt and equity financing with Deerfield Management Company, L.P. (Deerfield), a New York headquartered healthcare investment firm. SHINE plans to build a new manufacturing plant in Wisconsin to produce more than a quarter of world supply of the most commonly-used isotope in nuclear medicine, molybdenum-99 (moly-99)...Read More

SHINE Medical and Phoenix Nuclear Achieve Key Technical Milestone

Phoenix Nuclear Labs
August 12, 2014

SHINE Medical Technologies and Phoenix Nuclear Labs (PNL) announced today that they successfully operated their second-generation neutron driver prototype for 24 consecutive hours with 99% uptime. Completion of this milestone is an important demonstration of the reliability and robustness of the PNL neutron driver, which is a key enabling technology for SHINE’s isotope production facility...Read More

SHINE to Hold Information Session

June 16, 2014

SHINE Medical Technologies, Inc. (SHINE Medical), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that it will present an update on its progress in the development and planning for its Janesville medical isotope facility on Wednesday, June 18th at the Holiday Inn Express, 3100 Wellington Place in Janesville...Read More

James L. Connaughton Joins SHINE

May 15, 2014

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that James L. Connaughton has agreed to serve as a strategic advisor to management as SHINE continues its efforts to bring molybdenum-99 (moly-99) to market...Read More

SHINE to Supply Mo-99 to GE Healthcare

April 3, 2014

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin‐based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that it has entered into a strategic long‐term supply agreement with GE Healthcare, a division of the General Electric Company, for supply of molybdenum‐99 (moly‐99)...Read More

SHINE Construction Permit Application Accepted by NRC

December 4, 2013

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that the Nuclear Regulatory Commission (NRC) has accepted for review the second half of SHINE’s construction permit application to build a medical isotope production plant near Janesville, WI...Read More

SHINE to Hold Information Session

City-Of-Janesville-Logo
November 26, 2013

SHINE updates the Janesville Community. ..Read More

NRC Dockets SHINE Construction Permit Application

US-NRC Logo
July 4, 2013

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, and affordable production of medical isotopes and cancer treatment elements, has received notice that the Nuclear Regulatory Commission (NRC) has accepted the first part of its Construction Permit application for review and docketing. This is the first formal step by the NRC in the construction permitting process for the SHINE medical isotope facility in Janesville, Wisconsin...Read More

SHINE to Hold Information Session

City-Of-Janesville-Logo
June 5, 2013

SHINE Medical Technologies, Inc. (SHINE Medical), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that it will present an update on its progress in the development and planning for its Janesville medical isotope facility on Thursday, June 13th at the Holiday Inn Express, 3100 Wellington Place in Janesville...Read More

SHINE Files 2nd Part of NRC Construction Permit Application

PSAR
June 5, 2013

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, and affordable production of medical isotopes and cancer treatment elements, has submitted the remaining chapters of its Construction Permit application to the Nuclear Regulatory Commission (NRC)...Read More

Los Alamos Team Produces Mo-99 From Irradiation of LEU Solution

Los-Alamos-National-Labboratory-Logo
May 14, 2013

Today, Los Alamos National Laboratory announced that for the first time, irradiated low-enriched uranium (LEU) fuel has been recycled and reused for molybdenum-99 (Mo-99) production, with virtually no losses in Mo-99 yields or uranium recovery...Read More

SHINE Meets Major Milestone in Medical Isotope Production Effort

May 2, 2013

SHINE Medical Technologies (SHINE) announced today that its development program with Phoenix Nuclear Labs (PNL) reached an important technical milestone by successfully producing 3x1011 neutrons per second with the deuterium-deuterium fusion reaction. ..Read More